Monday - April 06, 2026

Category Archives: Science

Opioid Use Disorder Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Opioid Use Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. It covers the Opioid Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Knee Osteoarthritis Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Knee Osteoarthritis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Knee Osteoarthritis pipeline landscape. It covers the Knee Osteoarthritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

BK Virus Infection Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “BK Virus Infection Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in BK Virus Infection pipeline landscape. It covers the BK Virus Infection pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Postpartum Depression Clinical Trial Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

DelveInsight’s, “Postpartum Depression Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum Depression pipeline landscape. It covers the Postpartum Depression pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Liver Fibrosis Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Liver Fibrosis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Liver Fibrosis pipeline landscape. It covers the Liver Fibrosis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Metastatic Hormone Refractory Prostate Cancer Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Metastatic Hormone Refractory Prostate Cancer Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Metastatic Hormone Refractory Prostate Cancer pipeline landscape. It covers the Metastatic Hormone Refractory Prostate Cancer Pipeline drug profiles, … Continue reading →

Alibaba Launches Wan 2.7: Breakthrough AI Image & Video Generation Model with Thinking Mode

Wan 2.7-generated image demonstrating hyper-realistic character details and precise color control Alibaba’s Tongyi Lab has officially released Wan 2.7, the latest major upgrade to its Wan (Wanxiang) AI series. Featuring innovative “Thinking Mode”, hyper-realistic character consistency, precise color control, superior … Continue reading →

Detecting Financial Fraud in Real-Time Transactions Using Graph Neural Networks and Anomaly Detection Techniques

The research “Detecting Financial Fraud in Real-Time Transactions Using Graph Neural Networks and Anomaly Detection Techniques” presents an AI-driven system for real-time fraud detection in digital payments. Using Graph Neural Networks and anomaly detection, the model analyzes transaction relationships and … Continue reading →

Motor Neuron Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 180+ Key Companies | DelveInsight

DelveInsight’s, “Motor Neuron Disease Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Motor Neuron Disease pipeline landscape. It covers the Motor Neuron Disease pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Melanoma Clinical Trial Pipeline Gains Momentum: 150+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Melanoma Pipeline Insights 2026” report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in the Melanoma Pipeline landscape. It covers the Melanoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Melanoma pipeline … Continue reading →